lilly glp-1 drug Diabetes Patients Also Struggle to Access Agonists Lilly is now pharma's top

For more on converting between units and milligrams of tirzepatide , our dedicated conversion guides walk through every common scenario

D.TomashevskiA

The most extensively studied compounds are exenatide (Byetta [Amylin Pharmaceuticals, San Diego, CA], which has been approved by the US Food and Drug Administration [FDA] for the treatment of type 2 diabetes), liraglutide (Victoza [Novo Nordisk, Princeton, NJ], which has been submitted to the FDA for approval), sitaglitptin (Januvia [Abbott Laboratories, Abbott Park, IL], which has been approved by the FDA for type 2 diabetes), and vildagliptin (Galvus [Novo Nordisk, Princeton, NJ], which has been submitted to FDA)

Cost: Approximately $150-$300 monthly ($1800-$3600 yearly) for peptides plus $200-$500 yearly for exams and AREDS2 supplements